JANIE DINH: Open Payments
NPI 1346803103 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 33 payments from 11 companies in 2025. Trend: 2023 $13 · 2024 $365 · 2025 $986
Food & beverage: $986
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $224 |
| Kowa Pharmaceuticals America, Inc. | 7 | $208 |
| Novo Nordisk Inc | 5 | $194 |
| SANOFI-AVENTIS U.S. LLC | 1 | $104 |
| PFIZER INC. | 3 | $70 |
| ABBVIE INC. | 3 | $56 |
| Lilly USA, LLC | 2 | $46 |
| Edwards Lifesciences Corporation | 1 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $20 |
| Currax Pharmaceuticals LLC | 1 | $16 |
Products named: ZORYVE, Ozempic, AIRSUPRA, TZIELD, FARXIGA, VRAYLAR, MOUNJARO, SAPIEN 3 Ultra RESILIA.
Industry payments across GA — which companies pay providers there.
